← MOLECULAR PARTNERS AG

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $20.4m $9.3m $9.8m $189.6m $7.0m $5.0m $0
Revenues from research and development collaborations $20.4m $9.3m $9.3m $189.6m $7.0m $5.0m $0
Research and development — $56.1m $55.7m $50.7m $48.8m $48.6m $40.2m
Operating expenses:
Other Operating Expenses — — ($424k) ($44k) — — —
Total operating expenses ($57.0m) ($67.7m) ($73.2m) ($73.0m) ($68.1m) ($66.2m) ($58.1m)
EBIT $118.5m ($62.0m) ($54.0m) ($61.6m)
Additional Financial Items
Applicable Tax Rate — $0 $0 $0 $0 $0 $0
Average Effective Tax Rate — — — — — — $0
Depreciation Right of Use Assets — $1.3m $1.2m $1.2m $1.2m $1.2m $1.2m
Finance Income $1.6m $367k $191k $1.9m $4.3m $7.2m $1.5m
Other Income — $0 $424k $44k $0 $0 —
Profit Loss Before Tax ($36.3m) ($62.8m) ($63.8m) $117.9m ($62.0m) ($54.0m) ($61.6m)
Profit Loss From Operating Activities ($36.7m) ($58.3m) ($63.4m) $116.6m ($61.1m) ($61.2m) ($58.1m)
Operating result ($36.7m) ($58.3m) ($63.4m) $116.6m ($61.1m) ($61.2m) ($58.1m)
Financial income $1.6m $367k $191k $1.9m $4.3m $7.2m $1.5m
Net finance result $389k ($4.4m) ($365k) $1.2m ($876k) $7.2m ($3.5m)
Result before income taxes ($36.3m) ($62.8m) ($63.8m) $117.9m ($62.0m) ($54.0m) ($61.6m)
Income taxes ($17k) $11k ($2k) $0 $0 ($2k) ($2k)
Net result, attributable to shareholders ($36.3m) ($62.8m) ($63.8m) $117.9m ($62.0m) ($54.0m) ($61.7m)
Remeasurement of net pension liabilities ($4.7m) ($1.5m) $8.0m $5.3m ($2.0m) ($485k) ($3.8m)
Exchange differences on translating foreign operations ($14k) ($26k) ($3k) ($17k) ($16k) ($10k) $5k
Other comprehensive result, net of tax ($4.7m) ($1.5m) $8.0m $5.3m ($2.0m) ($495k) ($3.8m)
Depreciation Amortization Depletion Income Statement — — — $416k $367k $419k $371k
Depreciation And Amortization In Income Statement — — — $416k $367k $419k $371k
Diluted EPS ($1.69) ($2.51) ($2.06) $3.54 ($1.89) ($1.59) ($1.65)
Diluted NI Availto Com Stockholders ($36.3m) ($62.8m) ($63.8m) $117.9m ($62.0m) ($54.0m) ($61.7m)
Gain On Sale Of Security — — — $717k ($5.1m) $3.8m ($5.0m)
Interest Income — — — $1.1m $4.3m $3.4m $1.5m
Interest Income Non Operating — — — $1.1m $4.3m $3.4m $1.5m
Net Income From Continuing And Discontinued Operation ($36.3m) ($62.8m) ($63.8m) $117.9m ($62.0m) ($54.0m) ($61.7m)
Net Income From Continuing Operation Net Minority Interest ($36.3m) ($62.8m) ($63.8m) $117.9m ($62.0m) ($54.0m) ($61.7m)
Net Interest Income — — — $523k $4.2m $3.3m $1.5m
Normalized EBITDA — — — $120.1m ($54.4m) ($55.5m) ($51.8m)
Normalized Income — — — $117.3m ($57.9m) ($57.5m) ($54.6m)
Other Gand A — — — $10.0m $7.4m $6.2m $5.1m
Reconciled Depreciation — — — $2.4m $2.4m $2.4m $2.1m
Restructuring And Mergern Acquisition — — — — $0 $0 $2.7m
Salaries And Wages — — — $11.8m $11.6m $11.0m $9.8m
Selling General And Administration — — — $21.8m $19.0m $17.2m $14.9m
Special Income Charges — — — — $0 $0 ($2.7m)
Tax Effect Of Unusual Items — — — $139k ($985k) $326k ($655k)
Tax Provision — ($11k) $2k $0 $0 $2k $2k
Tax Rate For Calcs — — — $0 $0 $0 $0
Net Foreign Exchange Loss — $4.5m $0 $0 $5.1m $0 $5.0m
Total comprehensive result, attributable to shareholders ($41.0m) ($64.3m) ($55.8m) $123.2m ($64.0m) ($54.5m) ($65.5m)
Total Unusual Items — — — $717k ($5.1m) $3.8m ($7.7m)
Total Unusual Items Excluding Goodwill — — — $717k ($5.1m) $3.8m ($7.7m)
Pre-Tax Income ($36.3m) ($62.8m) ($63.8m) $117.9m ($62.0m) ($54.0m) ($61.6m)
Net Income ($36.3m) ($62.8m) ($63.8m) $117.9m ($62.0m) ($54.0m) ($61.7m)
Net Income Continuous Operations ($36.3m) ($62.8m) ($63.8m) $117.9m ($62.0m) ($54.0m) ($61.7m)
Net Income Including Noncontrolling Interests ($36.3m) ($62.8m) ($63.8m) $117.9m ($62.0m) ($54.0m) ($61.7m)
Basic Earnings (Loss) Per Share ($1.69) ($2.51) ($2.06) $3.63 ($1.89) ($1.59) ($1.65)
Diluted Earnings (Loss) Per Share ($1.69) ($2.51) ($2.06) $3.54 ($1.89) ($1.59) ($1.65)
Basic Average Shares — — — $32.5m $32.8m $34.0m $37.3m
Diluted Average Shares — — — $33.3m $32.8m $34.0m $37.3m
Research and development expenses ($43.5m) ($56.1m) ($55.7m) ($50.7m) ($48.8m) ($48.6m) ($40.2m)
Selling, General and Administrative Expense — $11.6m $17.5m $22.2m $19.4m $17.6m $15.2m
Selling, general and administrative expenses ($13.5m) ($11.6m) ($17.5m) ($22.2m) ($19.4m) ($17.6m) ($15.2m)
Employee Benefits Expense — $33.6m $36.3m $39.9m $40.0m $37.7m $37.4m
Expense From Share-Based Payment Transactions With Employees — $2.9m $4.1m $5.1m $5.2m $4.1m $4.3m
Expense Relating To Short-Term Leases For Which Recognition Exemption Has Been Used — $0 $0 $0 $0 $0 $0
Finance Costs — $4.8m $556k $619k $5.2m $38k $5.0m
Other Employee Expense — $1.7m $663k $1.5m $3.0m $2.6m $2.5m
Other Finance Cost — $9k $8k $14k $15k $13k $15k
Postemployment Benefit Expense Defined Benefit Plans — $3.1m $3.1m $3.2m $2.6m $1.5m $1.6m
Restructuring expenses — — — — $0 $0 ($2.7m)
Financial expenses ($1.2m) ($4.8m) ($556k) ($619k) ($5.2m) ($38k) ($5.0m)
Interest Expense On Lease Liabilities — $24k $53k $43k $34k $24k $18k
Income Tax Expense Continuing Operations — ($11k) $2k $0 $0 $2k $2k
General And Administrative Expense — — — $21.8m $19.0m $17.2m $14.9m
Interest Expense — — — $605k $34k $25k $18k
Interest Expense Non Operating — — — $605k $34k $25k $18k
Net Non Operating Interest Income Expense — — — $523k $4.2m $3.3m $1.5m
Operating Expense — — — $72.9m $68.1m $66.2m $55.4m
Other Income Expense — — — $717k ($5.1m) $3.8m ($7.7m)
Total Expenses — — — $72.9m $68.1m $66.2m $55.4m
Total Other Finance Cost — $9k $8k $14k $15k $13k $15k

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.